Skip to content

Clinical trials

Oppositional Defiant Disorder trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Oppositional Defiant Disorder Clear all

85 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20033
20043
20051
20067
20071
20081
20091
20102
20116
20122
20145
20154
20164
20177
20183
20193
20202
20212
20226
20232
20247
20256
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed59
Recruiting12
Unknown status7
Not yet recruiting3
Active, not recruiting2
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Karolinska Institutet6
University of Pittsburgh4
Centre for Addiction and Mental Health3
Eli Lilly and Company3
University of South Florida3
Florida International University2
IRCCS Fondazione Stella Maris2
Indiana University2
Janssen Pharmaceutica N.V., Belgium2
Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospital2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Oppositional Defiant Disorder85
Conduct Disorder44
Attention Deficit Disorder with Hyperactivity43
Attention Deficit and Disruptive Behavior Disorders17
Anxiety Disorders10
Mental Disorders8
Autistic Disorder3
Child Development Disorders, Pervasive3
Depressive Disorder3
Disruptive, Impulse Control, and Conduct Disorders3

Trials

Showing 1 to 25 of 85. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.